The significance of perioperative transfusions on short- and long-term outcome after curative-intended liver resection. - A retrospective analysis based on a liver surgery database of the University Hospital Dresden, referring to the years 2013 - 2021.
- Conditions
- iver resection regardless of underlying diagnosis
- Registration Number
- DRKS00032302
- Lead Sponsor
- niversitätsklinikum Carl Gustav Carus Dresden an der TU Dresden, Klinik und Poliklinik für Viszeral-, Thorax- und Gefäßchirurgie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 1118
Inclusion Criteria
All patients recorded in the liver database of the Department of Visceral, Thoracic and Vascular Surgery who underwent liver resection (regardless of underlying diagnosis) in the UKD (VTG) from 2013-2021.
Exclusion Criteria
Not applicable
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Analysis and presentation of patient characteristics, perioperative parameters, postoperative parameters.
- Secondary Outcome Measures
Name Time Method - Univariate and multivariate analysis to identify risk factors for morbidity, mortality, and reoperation rates, as well as long-term oncologic outcome and the need for blood transfusion<br>- Comparative subgroup analysis between patients with and without perioperative blood transfusion after liver surgery<br>- Kaplan-Meier analysis of overall and recurrence-free survival
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link perioperative blood transfusions to post-liver resection outcomes in oncology patients?
How do transfusion-related adverse events impact long-term survival after curative liver resection for hepatocellular carcinoma?
What biomarkers correlate with transfusion requirements in liver resection for metastatic colorectal cancer?
How does perioperative transfusion compare to standard-of-care anemia management in liver surgery oncology?
What are the implications of transfusion-associated immunomodulation on recurrence rates after liver resection for cholangiocarcinoma?